Topics
July/August 2018 | Subfocus: Drug Delivery
Topical Drug Delivery for Retinal Disease Management
The cornea and sclera stand in the way of this more convenient, less invasive drug delivery modality.
David S. Boyer, MD
October 1, 2026
Atsena Reports 18-Month ATSN-201 Results in X-Linked Retinoschisis
Galimedix Highlights Patient-Tailored Microperimetry in Phase 2 eDREAM Geographic Atrophy Study
Nanoscope’s Mogenry Granted Priority Review in Japan for Inherited Retinal Dystrophies
September 30, 2026
Heidelberg Engineering to Showcase Imaging, Surgical Visualization Advances at AAO 2026
September 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent supported by Abbvie and Regenxbio
September 2026 Supplement
Content Sponsored by Apellis, A subsidiary of Biogen
Editorially independent content supported with advertising by Eyepoint
This activity is supported by an independent educational grant from AlconVision, LLC
View Program
This program will open on EvolveMedEd.com.
Free Print Subscription
Email Newsletter
Conference Calendar
